Kang NS - Search Results

1

Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation.

Balupuri A, Lee MH, Chae S, Jung E, Yoon W, Kim Y, Son SJ, Ryu J, Kang DH, Yang YJ, You JN, Kwon H, Jeong JW, Koo TS, Lee DY, Kang NS. Balupuri A, et al. Among authors: kang ns, kang dh. Eur J Med Chem. 2018 Mar 25;148:397-409. doi: 10.1016/j.ejmech.2018.02.049. Epub 2018 Feb 17. Eur J Med Chem. 2018. PMID: 29477073

2

Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.

Ahn JH, Shin MS, Jun MA, Jung SH, Kang SK, Kim KR, Rhee SD, Kang NS, Kim SY, Sohn SK, Kim SG, Jin MS, Lee JO, Cheon HG, Kim SS. Ahn JH, et al. Among authors: kang sk, kang ns. Bioorg Med Chem Lett. 2007 May 1;17(9):2622-8. doi: 10.1016/j.bmcl.2007.01.111. Epub 2007 Feb 8. Bioorg Med Chem Lett. 2007. PMID: 17331715

3

Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.

Kang NS, Ahn JH, Kim SS, Chae CH, Yoo SE. Kang NS, et al. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3716-21. doi: 10.1016/j.bmcl.2007.04.031. Epub 2007 Apr 13. Bioorg Med Chem Lett. 2007. PMID: 17462890

4

Synthesis and biological evaluation of pyrazoline analogues with beta-amino acyl group as dipeptidyl peptidase IV inhibitors.

Jun MA, Park WS, Kang SK, Kim KY, Kim KR, Rhee SD, Bae MA, Kang NS, Sohn SK, Kim SG, Lee JO, Lee DH, Cheon HG, Kim SS, Ahn JH. Jun MA, et al. Among authors: kang sk, kang ns. Eur J Med Chem. 2008 Sep;43(9):1889-902. doi: 10.1016/j.ejmech.2007.11.029. Epub 2007 Dec 14. Eur J Med Chem. 2008. PMID: 18243422

5

Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.

Lee JH, Kang NS, Yoo SE. Lee JH, et al. Among authors: kang ns. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2479-90. doi: 10.1016/j.bmcl.2008.02.042. Epub 2008 Feb 19. Bioorg Med Chem Lett. 2008. PMID: 18314331

6

Effect of novel N-cyano-tetrahydro-pyridazine compounds, a class of cathepsin K inhibitors, on the bone resorptive activity of mature osteoclasts.

Kim SH, Jhon DJ, Song JH, No JS, Kang NS. Kim SH, et al. Among authors: kang ns. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3988-91. doi: 10.1016/j.bmcl.2008.06.017. Epub 2008 Jun 10. Bioorg Med Chem Lett. 2008. PMID: 18571402

7

Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors.

Ahn JH, Park WS, Jun MA, Shin MS, Kang SK, Kim KY, Rhee SD, Bae MA, Kim KR, Kim SG, Kim SY, Sohn SK, Kang NS, Lee JO, Lee DH, Cheon HG, Kim SS. Ahn JH, et al. Among authors: kang sk, kang ns. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6525-9. doi: 10.1016/j.bmcl.2008.10.076. Epub 2008 Oct 21. Bioorg Med Chem Lett. 2008. PMID: 18996694

8

Classification models for CYP450 3A4 inhibitors and non-inhibitors.

Choi I, Kim SY, Kim H, Kang NS, Bae MA, Yoo SE, Jung J, No KT. Choi I, et al. Among authors: kang ns. Eur J Med Chem. 2009 Jun;44(6):2354-60. doi: 10.1016/j.ejmech.2008.08.013. Epub 2008 Sep 18. Eur J Med Chem. 2009. PMID: 19026469

9

Predictive models of Cannabinoid-1 receptor antagonists derived from diverse classes.

Kang NS, Lee GN, Yoo SE. Kang NS, et al. Bioorg Med Chem Lett. 2009 Jun 1;19(11):2990-6. doi: 10.1016/j.bmcl.2009.04.037. Epub 2009 Apr 17. Bioorg Med Chem Lett. 2009. PMID: 19406638

10

Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.

Cho SY, Han SY, Ha JD, Ryu JW, Lee CO, Jung H, Kang NS, Kim HR, Koh JS, Lee J. Cho SY, et al. Among authors: kang ns. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4223-7. doi: 10.1016/j.bmcl.2010.05.031. Epub 2010 May 15. Bioorg Med Chem Lett. 2010. PMID: 20570511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page